This is a routine weekly disclosure of ongoing share repurchases with no new strategic information. The buyback is proceeding at a steady pace. Monitor the next quarterly earnings (20-F annual report filed February 2026) for fundamental business trends and any updates to the capital return policy.
Price Chart
Executive Summary
Novo Nordisk filed a routine 6-K disclosing weekly share repurchase transactions under its existing DKK 15 billion buyback program. Since February 4, 2026, the company has repurchased 19,884,179 B shares at an average price of DKK 264.99, totaling DKK 5.27 billion. This is a routine capital allocation update with no material new information.
Key Facts
- Overall buyback program of up to DKK 15 billion over 12 months beginning February 4, 2026
- As of June 12, 2026, Novo Nordisk has repurchased 19,884,179 B shares at an average price of DKK 264.99 per share, totaling DKK 5,269,055,819
- Under the sub-program initiated May 6, 2026, up to DKK 11.2 billion in B shares will be repurchased through February 1, 2027
- Novo Nordisk holds 37,069,480 B shares as treasury shares, representing 0.8% of total share capital of 4,465,000,000 shares
- Weekly transactions from June 8-12, 2026 totaled 1,125,000 B shares at an average price range of DKK 268.40 to DKK 283.72
Financial Impact
Routine buyback update; cumulative repurchases of DKK 5.27 billion represent ~35% of the DKK 15 billion program authorization
Risk Factors
- No new financial or operational data provided in this filing
- Share repurchase pace does not indicate underlying business performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-004116 |
| Document: 0001171843-26-004116-index-headers.html | 0001171843-26-004116 |
| Document: 0001171843-26-004116-index.html | 0001171843-26-004116 |
| Document: 0001171843-26-004116.txt | 0001171843-26-004116 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 6-K | $39.13 | awaiting T+20 | awaiting T+20 | $38.67 (−1.18%) |
Oct 26, 2026 2d ago | Court Ruling | $38.59 | awaiting T+20 | awaiting T+20 | $38.67 (+0.21%) |
Oct 19, 2026 8d ago | 6-K | $38.42 | awaiting T+20 | awaiting T+20 | $38.67 (+0.65%) |
Oct 13, 2026 14d ago | 6-K | $38.06 | awaiting T+20 | awaiting T+20 | $38.67 (+1.60%) |
Oct 6, 2026 21d ago | 6-K | $37.53 | awaiting T+20 | awaiting T+20 | $38.67 (+3.04%) |
Sep 28, 2026 29d ago | 6-K | $38.71 $38.95 | ▲ +0.61% | ▲ +0.64% | $38.67 (−0.10%) |
Sep 23, 2026 5w ago | Court Ruling | $38.62 $39.43 | ▲ +2.10% | ▲ +2.52% | $38.67 (+0.13%) |
Sep 21, 2026 5w ago | 6-K | $39.80 $38.42 | ▼ −3.47% | ▼ −2.56% | $38.67 (−2.84%) |
Sep 17, 2026 5w ago | 6-K | $43.19 $39.22 | ▼ −9.19% | ▼ −10.40% | $38.67 (−10.47%) |
Sep 15, 2026 6w ago | 6-K | $42.53 $38.06 | ▼ −10.51% | ▼ −13.23% | $38.67 (−9.08%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers